Platelet Activation Through G-protein Coupled Receptors

Platelet contains G-protein coupled receptors (GPCRs) that play a key role in platelet activation and thrombus formation in response to various agonists including ADP, thromboxane A<sub>2</sub>, thrombin, epinephrine, and serotonin by coupling to various G-proteins. Since platelets play an important role in health and diseases, platelet GPCRs have been one of the primary drug targets. However, progress should be made in our understanding of GPCR dynamics, activation, and signaling to open new possibilities for selective drug development. In this review, we have summarized the platelet GPCRs, their associated G-protein signaling, and the downstream signaling mechanism that results in both activation and desensitization of platelets. A deeper understanding of the processes behind GPCR-mediated signaling might enable antiplatelet medication to be customized in the future.

Authors

Institutions

Publication Details

Journal
Clinical & Experimental Thrombosis and Hemostasis
Published
2024-11-10
DOI
https://doi.org/10.14345/ceth.24002
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Platelet Activation Through G-protein Coupled Receptors

Soochong Kim, Sanggu Kim, Preeti Kumari Chaudhary
Clinical & Experimental Thrombosis and Hemostasis
Antiplatelet Therapy and Cardiovascular Diseases
article

Platelet Activation Through G-protein Coupled Receptors

Soochong Kim, Sanggu Kim, Preeti Kumari Chaudhary
article en

Abstract

Platelet contains G-protein coupled receptors (GPCRs) that play a key role in platelet activation and thrombus formation in response to various agonists including ADP, thromboxane A<sub>2</sub>, thrombin, epinephrine, and serotonin by coupling to various G-proteins. Since platelets play an important role in health and diseases, platelet GPCRs have been one of the primary drug targets. However, progress should be made in our understanding of GPCR dynamics, activation, and signaling to open new possibilities for selective drug development. In this review, we have summarized the platelet GPCRs, their associated G-protein signaling, and the downstream signaling mechanism that results in both activation and desensitization of platelets. A deeper understanding of the processes behind GPCR-mediated signaling might enable antiplatelet medication to be customized in the future.

Clinical & Experimental Thrombosis and HemostasisVol. 9(2)
Chungbuk National University (KR)
Openalex Percentile: Top 58%
Antiplatelet Therapy and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.